Escolar Documentos
Profissional Documentos
Cultura Documentos
CONTENTS
Update on current management of TB in children & pregnant women Latest antiTB regimens & dosages in children
TB IN CHILDREN
TB in children is increasing in Malaysia
High risk of active disease in infants & children under 5 years of age Active TB usually develops within 2 years of infection but can be as short as a few weeks in infants
TB IN CHILDREN
PTB & lymph node TB - commonest presentations
COMMON CLINICAL PRESENTATIONS OF TB IN CHILDREN Prolonged fever Failure to thrive Unresolved pneumonia Persistent lymphadenopathy
RECOMMENDATION 18
Children suspected of PTB should have sputum examination, CXR & TST performed. (Grade C)
Gastric lavage/aspiration should be performed in infants & children who are unable to expectorate sputum. (Grade C)
Remarks
Ethambutol can be added in the intensive phase of suspected isoniazidresistance or extensive pulmonary disease cases.
2HRZE 2HRZE
4HR 10HR
10
Treatment failure TB
MDR-TB
Individualised regimen
RECOMMENDATION 19
All children with TB should be given standardised treatment regimens & dosages according to the relevant diagnostic categories. (Grade C)
13
LATENT TB INFECTION (LTBI) IN CHILDREN LTBI : infected with M.tuberculosis but patient is asymptomatic. Active TB disease : Symptomatic TB infection. Children younger than 5 years old with LTBI has 10 - 20% risk of developing active TB disease. (Horsburgh CR Jr, 2004)
14
DIAGNOSTIC TESTS FOR LTBI IN CHILDREN LTBI is suspected in children exposed to active TB person For child contact: perform CXR & TST Sputum AFB smear is not required in asymptomatic child being investigated for LTBI Symptomatic child: examine & investigate for active TB & other diseases as indicated
15
INTERFERON GAMMA RELEASE ASSAY IN CHILDREN The amount of Interferon Gamma (IFN-y) released is correlated directly with age (p<0.0001). (Lighter J et al., Pediatrics. 2009)
IGRA test is less likely to be positive in children < 2 years of age. The sensitivity of both IGRAs & TST are reduced in young or HIV-positive children.
(WHO, 2011)
16
RECOMMENDATION 20
TST should be used as a standard test to diagnose LTBI in children. (Grade C) IGRA should not be used as a replacement for TST in diagnosing LTBI in children. (Grade C)
17
TREATMENT OF LTBI IN CHILDREN Active TB must be ruled out before starting LTBI treatment. Therapeutic regimens: Isoniazid: 6 months Isoniazid plus rifampicin : 3 months
WHO,2006 Panickar JR et al., Eur Respir J., 2007 Spyridis NP et al ., Clin Infect Dis., 2007.
18
RECOMMENDATION 21
Non-HIV infected children with LTBI should be treated with 6-month of isoniazid or 3-month of isoniazid plus rifampicin. (Grade C)
19
BCG LYMPHADENITIS
Develop 2 - 4 months after vaccination Usually self-limiting No evidence of benefit from medical therapy.
Erythromycin, isoniazid and rifampicin
Suppuration can occur in 30 - 80% If LN >3 cm & fluctuant: needle aspiration surgical excision (if recurring)
Banani SA et al., Arch Dis Child., 1994 Goraya JS et al., Postgrad Med J., 2002
21
RECOMMENDATION 22
Medical therapy should not be offered routinely in BCG lymphadenitis. (Grade C)
22
CONGENITAL & PERINATAL TB Congenital TB is rare Active maternal TB during delivery: take samples or biopsy for MTB culture & HPE Perinatal TB infection is suspected when infant does not respond to standard treatment
Coulter JB et al., Ann Trop Paediatr., 2011 Whittaker et al., Early Hum Dev., 2008 Smith KC et al., Curr Opin Infect Dis., 2002
23
MANAGEMENT OF NEWBORNS Defer BCG at birth & perform full TB investigations if: mother diagnosed <2 mths before delivery or did not receive adequate treatment mother is sputum positive just before delivery the newborn is symptomatic Treat as active TB if indicated
WHO, 1998
24
MANAGEMENT OF NEWBORNS INH as prophylaxis: 2 regimens a) INH for 6 mths b) INH for 3 mths & followed by mantoux test: o <5 mm - stop INH, give BCG o 5 mm - complete INH for 6 mths, give BCG Any symptoms suggestive of TB disease: repeat TB work up, treat as TB
25
RECOMMENDATION 23
BCG should not be given to babies on prophylactic TB treatment. (Grade C) Prophylactic TB treatment should be given to babies born to mothers with active PTB except those diagnosed more than 2 months before delivery who have documented smear negative before delivery. (Grade C)
27
TB IN PREGNANCY & LACTATION Increased risk of maternal & perinatal morbidity First-line antiTB drugs are safe in pregnancy & breastfeeding Streptomycin: avoid during pregnancy risk of foetal ototoxicity
Ormerod P, Thorax, 2001
28
TB IN PREGNANCY & LACTATION Breastfeeding should be continued Surgical mask should be used if the mother is still infectious Pyridoxine should be given to mothers taking isoniazid Infant-mother separation is considered if the mother has MDR-TB or is non-compliant to treatment
Ormerod P, Thorax, 2001
29
ORAL CONTRACEPTIVE PILLS & ANTITB DRUGS Rifamycin (rifampicin & rifabutin) reduces the efficacy of both combined oral contraceptives & progesterone-only pills
Alternative contraceptive method should be used during & for 1 month after stopping rifamycins
NZMoH; 2010
30
RECOMMENDATION 24
All women of child bearing age suspected of TB should be asked about current or planned pregnancy. (Grade C) First-line antiTB drugs except streptomycin can safely be used in pregnancy. (Grade C) First-line antiTB drugs can safely be used in breastfeeding. (Grade C) Pyridoxine supplementation should be given to all pregnant and breastfeeding women taking isoniazid. (Grade C) Patient on rifampicin should use alternative contraception methods other than oral contraceptives and progesteroneonly pills. (Grade C)
31
TAKE HOME MESSAGES TB IN CHILDREN Children <5years old have high risk of developing active TB disease Defer BCG in newborns at risk of perinatal TB until INH completed. TST and CXR should be performed in all child contacts . BCG lymphadenitis does not require antibiotic.
32
TAKE HOME MESSAGES MATERNAL TB First-line antiTB drugs are safe in pregnancy & lactation. Streptomycin must be avoided in pregnancy. Rifamycins reduce the efficacy of OCPs.
33
THANK YOU
drsuryati_adnan@phg.moh.gov.my jaynachi@gmail.com jumeah70@yahoo.com
34